XML 16 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations Statement - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
REVENUE:        
Services $ 117,239 $ 118,172 $ 238,175 $ 240,942
Product sales 46,664 29,897 83,535 60,774
Total revenue 163,903 148,069 321,710 301,716
OPERATING EXPENSES:        
Cost of services, exclusive of depreciation expense shown below 80,431 83,349 164,032 168,643
Cost of product sales, exclusive of depreciation expense shown below 36,687 26,650 67,658 54,170
General and administrative expense, exclusive of depreciation expense shown below 11,100 11,139 23,856 22,189
Depreciation 6,093 6,531 12,295 13,158
Amortization 209 220 434 440
Other (income) expense, net (24) (47) 849 (51)
OPERATING INCOME 29,407 20,227 52,586 43,167
Interest expense 2,692 3,021 5,310 6,455
Income before income tax expense 26,715 17,206 47,276 36,712
Income tax expense 4,006 671 6,885 5,060
Net income 22,709 16,535 40,391 31,652
Net income (loss) attributable to non-controlling interest 19 (89) 43 (54)
Net income attributable to Core Laboratories N.V. $ 22,690 $ 16,624 $ 40,348 $ 31,706
EARNINGS PER SHARE INFORMATION:        
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share) $ 0.51 $ 0.38 $ 0.91 $ 0.74
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share) 0.51 0.38 0.91 0.74
Cash dividends per share (in dollars per share) $ 0.55 $ 0.55 $ 1.10 $ 1.10
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 44,164 43,297 44,162 42,839
Diluted 44,374 43,505 44,360 43,008